DEBBANE RAYMOND purchased 5.5% of their position (100K shares) of LEXICON PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $147.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/25/2026ACC: 0001062822-26-000032
Director
Since Feb 2026
+100K
Net shares
Net buyer
$147.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$1.47
Trade value
$147K
% of position
5.5%
2/23/2026
1.80M→1.90M
Total
Net shares
+100K
Net value
$147K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | P · Purchase | +100K | $1.47 | $147K | 5.5% | 1.80M | 1.90M |
| Total | +100K | $147K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned7.36M
Common Stock
IndirectShares owned1.54M
Common Stock
IndirectShares owned35.40M
Common Stock
IndirectShares owned5.45M
Total
49.75M indirect49.75M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7.36M | Indirect |
| Common Stock | 1.54M | Indirect |
| Common Stock | 35.40M | Indirect |
| Common Stock | 5.45M | Indirect |
| Total | 49.75M | 49.75M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported